A study led by a CHOP neonatology expert showed that infants with severe retinopathy of prematurity (ROP) diagnosed and treated under modern protocols remain at risk of nonvisual disabilities, even if blindness can be averted in most children.
Monthly Archive: May 2014
For medical devices, as with many medicines, the market for children is a small fraction of the adult market, and there are far fewer child-sized devices. But the need for pediatric medical devices exists, even if proper devices may not.
Dr. Grupp has received a great deal of attention for his investigation of using cell therapy to treat an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL).
Beverly J. Lange, MD, an exemplary physician and researcher at The Children’s Hospital of Philadelphia (CHOP) for over 40 years, received the 2014 Distinguished Career Award from the American Society of Pediatric Hematology/Oncology (ASPHO).
Neonatologists at The Children’s Hospital of Philadelphia frequently face the intricate decision of whether to place a tracheostomy in a preterm infant with severe lung disease and when to do it. A lack of relevant literature about this procedure makes it a challenging consideration.
The Advances in Neuroblastoma Research Association (ANRA) recently presented its highest honor to pediatric oncologist Garrett M. Brodeur, MD, of the Cancer Center at The Children’s Hospital of Philadelphia (CHOP).
Most children with epilepsy can have active and fulfilling lives, with the help of modern therapies. Yet 20 percent to 30 percent of children with epilepsy do not respond to medications, which physicians call medication-resistant or intractable epilepsy.
The Children’s Hospital of Philadelphia launched the Violence Prevention Initiative (VPI) in January, which is taking a hospital-wide, multidisciplinary approach to curb youth violence in all forms.
Three studies under way at The Children’s Hospital of Philadelphia are looking at potential ways to desensitize children so that they can develop a level of tolerance to peanut protein that would provide some clinical protection against accidental exposure.
Jeffrey S. Gerber, MD, PhD, recently received an approximately $1.8 million contract from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of broad and narrow-spectrum antibiotics in treating acute respiratory infections.